TWC
OMGA

TD Waterhouse Canada’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

TD Waterhouse Canada’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-240
Closed -$866 – 1799
2022
Q2 		$866 Hold
240
– – ﹤0.01% 1633
2022
Q1 		$1.57K Buy
+240
New +$2.45K ﹤0.01% 1624

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

TD Waterhouse Canada's OMGA Position: Q3 2022 in Review

TD Waterhouse Canada sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q3 2022, closing a stake of 240 shares — an estimated $866 sold.

TD Waterhouse Canada first reported a position in OMGA in Q1 2022 and held it in 2 quarters. The position peaked at $1.57K in Q1 2022. 44 funds tracked by Wall St. Rank hold OMGA as of Q3 2022.

  • TD Waterhouse Canada reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • TD Waterhouse Canada sold 240 Omega Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $866.
  • TD Waterhouse Canada first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • TD Waterhouse Canada's Omega Therapeutics, Inc. Common Stock position peaked at $1.57K in Q1 2022.
  • 44 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q3 2022.

Based on TD Waterhouse Canada's 13F filing for Q3 2022, filed 13 Nov 2023.